TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: adherence to diabetes management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life for parents
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: prehension ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance on the Box and Blocks Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality imbalance
Endpoint domain: Mortality/survival
Primary endpoint: Sleep quality and duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Disease progression (DM)
Endpoint domain: Mortality/survival
Primary endpoint: Mean plasma half-life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations 2 h post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiovascular events frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MoCA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Major Cytogenetic Response (MCyR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hematological outcomes
Primary endpoint: Complete Cytogenetic Response (CCyR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hematological outcomes
Primary endpoint: Major Molecular Response (MMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hematological outcomes
Primary endpoint: frequency of allogenic transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Naked-eye eyesight improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal refractive status improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to cytotoxic chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to pain progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Motor Speed composite performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in AMS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sexual well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in hand-grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of premature LH rise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: amount of Cetrotide used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improved care quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COVID‐19‐related hospitalization or any‐cause death
Endpoint domain: Mortality/survival
Primary endpoint: mean reduction in viral load from baseline to Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy in managing PSCI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to HR ≥100 b.p.m.
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of positive pressure ventilation (PPV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of CA impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mean exposure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of transient facial nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: Willingness to pay for teledermoscopy service
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appointment access for buprenorphine prescribers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Median out-of-pocket costs for initial appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in mobility score at one year
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain score at one year
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Time to insert the nail
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean changes in cycloplegic autorefraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interobserver reliability for squamous mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraobserver reliability for squamous mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H. pylori seroprevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Knowledge of breastfeeding duration
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptance of WeChat feeding health education platform
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Major treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to arrest/incarceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSL distraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gross hardware failure
Endpoint domain: Adverse events/effects
Primary endpoint: Completeness of EGD reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of EGD reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reporting time for individual lesions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total costs per woman
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postpartum haemorrhage events
Endpoint domain: Adverse events/effects
Primary endpoint: Probability of a more desirable RADAR outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median number of antibiotic resistance genes per prokaryotic cell (RGPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EPAO nutrition score changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EPAO physical activity environment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital discharge criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COPD exacerbation detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC50 of remifentanil Ce
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC95 of remifentanil Ce
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GSRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: total CCAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full-term pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Infants with normal birth weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: SMART on FHIR app utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sIgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: salivary peanut sIgA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Global satisfaction and motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: C-SICI and TT-SICI relationship
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: TEP amplitude prediction by TT-SICI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: P30 generated with AP stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall performance in clinical post‐insertion CD flange adjustment procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for psychotic disorder
Endpoint domain: Mortality/survival
Primary endpoint: Risk for PE's
Endpoint domain: Mortality/survival
Primary endpoint: recurrence rate of EGW lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DXA T-scores for femur and vertebra
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and mineral outcomes
Primary endpoint: less crusting at Day 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: less downtime in the first 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brighter appearing skin at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Intraoperative anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Global health-related Quality of Life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VR-QOL improvement at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SWMt score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dual Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance to latest recommendations for ECR programme characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum electrolytes levels (Na, K, P, Mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Protection against HSV-1 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: maximum discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean adjusted excess weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean wear of dental crowns (μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESSPRI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ESSDAI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced confusion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Enhanced comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Public support for DCRs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postpartum dysglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients who became hypotensive after spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total dose of ephedrine administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: follicle diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACIT-Fatigue ≥3-point improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: FACIT-Fatigue ≥5-point improvement
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: FACIT-Fatigue normalization
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: EQ‐5D‐5L pain dimension
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ‐5D‐5L health scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum cotinine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c values decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in lipids profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in symptom severity over 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ongoing symptoms at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: MSI (Mean Scar Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OHIP-14 (Oral Health Impact Profile)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Painkiller consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Marginal bone level alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival rate (CSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical inactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-best-response survival
Endpoint domain: Mortality/survival
Primary endpoint: early tumor shrinkage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depth of response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of COVID-19 cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Contrast sensitivity with glare at 2.5°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increases in warm/heat thermal thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increased ability to name objects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Compliance questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anthropometric measurements (weight, body mass index, waist circumference, hip circumference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Causal effect of PTSD on AUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annual percent change in TKV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of scaphoid union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion of neurological status (AIS grade A to grade B or C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Immediate ATRA availability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Morbidity of patients with APL
Endpoint domain: Mortality/survival
Primary endpoint: Mortality of patients with APL
Endpoint domain: Mortality/survival
Primary endpoint: Change in spasticity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PillCam Crohn's score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Lewis inflammatory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of students with overweight or obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial skin load of C acnes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Postoperative ICU stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exposure time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation dose reduction (DLP and ED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health‐related QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Major arrhythmia occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Minor arrhythmia occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Daily internet usage
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Daily social media access
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Monthly health information search
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived risk of maternal influenza disease
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence in influenza vaccine efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived vaccine knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: spinal correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV testing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rescue medication consumption reductions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Active Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASDAS showing low disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASDAS showing inactive disease or ASAS showing partial remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of PB19 DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Concentration of PB19 DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of IgM antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Enrollment rate of contacted patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of unintentional injuries
Endpoint domain: Adverse events/effects
Primary endpoint: TMAO concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retear rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tendon healing rates to the bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the index test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the index test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants achieving at least 5% weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: negative mood valence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eradication of oncogenic HPVs
Endpoint domain: Mortality/survival
Primary endpoint: normalized reach distances in Y balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in cardiometabolic health markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resting potentiated high-frequency doublet (Db100)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: 50% decline in PSA (PSA50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FI scores of shoulder flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Picker patient experience score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postoperative opioid use in oral morphine equivalents per 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of POD
Endpoint domain: Mortality/survival
Primary endpoint: Early cerebral silent ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ≥90% seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: 100% seizure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Retention rates at 24 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thermic effect of food change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatocellular lipid levels change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Negative PANSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General psychopathology PANSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1 and FEV1/FVC percentage improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Average hospitalization time reduction
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: LVMi reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NT-proBNP concentration decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: P1NP concentration decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in discomfort of tinnitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes